235 related articles for article (PubMed ID: 10344709)
41. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant.
Bhutani VK; Abbasi S; Long WA; Gerdes JS
J Pediatr; 1992 Feb; 120(2 Pt 2):S18-24. PubMed ID: 1735846
[TBL] [Abstract][Full Text] [Related]
42. Exogenous surfactant use in neonates.
Ishisaka DY
Ann Pharmacother; 1996 Apr; 30(4):389-98. PubMed ID: 8729894
[TBL] [Abstract][Full Text] [Related]
43. One-year outcome in 232 premature infants with birth weights of 750 to 1249 grams and respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air placebo. Canadian Exosurf Neonatal Study Group.
Saigal S; Robertson C; Sankaran K; Bingham W; Casiro O; MacMurray B; Whitfield M; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S61-7. PubMed ID: 7745513
[TBL] [Abstract][Full Text] [Related]
44. Dose-response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS).
Häfner D; Beume R; Kilian U; Krasznai G; Lachmann B
Br J Pharmacol; 1995 Jun; 115(3):451-8. PubMed ID: 7582456
[TBL] [Abstract][Full Text] [Related]
45. Surfactant therapy in respiratory distress syndrome--the first local experience.
Lim NL; Nordin MM; Cheah IG
Med J Malaysia; 1994 Mar; 49(1):4-11. PubMed ID: 8057989
[TBL] [Abstract][Full Text] [Related]
46. Exogenous surfactants in a piglet model of acute respiratory distress syndrome.
Sood SL; Balaraman V; Finn KC; Britton B; Uyehara CF; Easa D
Am J Respir Crit Care Med; 1996 Feb; 153(2):820-8. PubMed ID: 8564138
[TBL] [Abstract][Full Text] [Related]
47. Double-blind 1-year follow-up of 1540 infants with respiratory distress syndrome randomized to rescue treatment with two doses of synthetic surfactant or air in four clinical trials. American and Canadian Exosurf Neonatal Study Groups.
Courtney SE; Long W; McMillan D; Walter D; Thompson T; Sauve R; Conway B; Bard H
J Pediatr; 1995 May; 126(5 Pt 2):S43-52. PubMed ID: 7745510
[TBL] [Abstract][Full Text] [Related]
48. Exosurf treatment investigational new drug phase: effect of an individualized third dose in infants with respiratory distress syndrome.
Easa D; Pelke S; Nakamura KT; Barrett J; Balaraman V; Loo SW; Ibarra-Pratt E; Smith MB
Pediatr Pulmonol; 1992 Sep; 14(1):16-22. PubMed ID: 1437338
[TBL] [Abstract][Full Text] [Related]
49. Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome.
Speer CP; Gefeller O; Groneck P; Laufkötter E; Roll C; Hanssler L; Harms K; Herting E; Boenisch H; Windeler J
Arch Dis Child Fetal Neonatal Ed; 1995 Jan; 72(1):F8-13. PubMed ID: 7743295
[TBL] [Abstract][Full Text] [Related]
50. Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
Drug Ther Bull; 1991 Jun; 29(12):46. PubMed ID: 1935584
[No Abstract] [Full Text] [Related]
51. Cost effects of surfactant therapy for neonatal respiratory distress syndrome.
Phibbs CS; Phibbs RH; Wakeley A; Schlueter MA; Sniderman S; Tooley WH
J Pediatr; 1993 Dec; 123(6):953-62. PubMed ID: 8229530
[TBL] [Abstract][Full Text] [Related]
52. One-year follow-up evaluation of 260 premature infants with respiratory distress syndrome and birth weights of 700 to 1350 grams randomized to two rescue doses of synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I.
Gong A; Anday E; Boros S; Bucciarelli R; Burchfield D; Zucker J; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S68-74. PubMed ID: 7745514
[TBL] [Abstract][Full Text] [Related]
53. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
Soll RF
Cochrane Database Syst Rev; 2000; (2):CD000144. PubMed ID: 10796308
[TBL] [Abstract][Full Text] [Related]
54. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
[TBL] [Abstract][Full Text] [Related]
55. Synthetic vs human surfactants in the treatment of respiratory distress syndrome: radiographic findings.
Levine D; Edwards DK; Merritt TA
AJR Am J Roentgenol; 1991 Aug; 157(2):371-4. PubMed ID: 1853824
[TBL] [Abstract][Full Text] [Related]
56. Single dose surfactant rescue therapy in neonatal respiratory distress syndrome.
Sanghvi KP; Merchant RH
Indian Pediatr; 1998 Jun; 35(6):533-6. PubMed ID: 10216648
[No Abstract] [Full Text] [Related]
57. [Exosurf-Neonatal: the synthetic surfactant. Introductory symposium, 20 June 1992].
Monatsschr Kinderheilkd; 1992 Sep; 140(9 [EXOSURF]):1-12. PubMed ID: 1406736
[No Abstract] [Full Text] [Related]
58. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.
Soll RF; Blanco F
Cochrane Database Syst Rev; 2001; (2):CD000144. PubMed ID: 11405951
[TBL] [Abstract][Full Text] [Related]
59. Criteria for use of colfosceril (Exosurf) in neonates.
Bhatt-Mehta V; Schumacher RE
Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234
[No Abstract] [Full Text] [Related]
60. Pulmonary hemorrhage in premature infants after treatment with synthetic surfactant: an autopsy evaluation. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group.
van Houten J; Long W; Mullett M; Finer N; Derleth D; McMurray B; Peliowski A; Walker D; Wold D; Sankaran K
J Pediatr; 1992 Feb; 120(2 Pt 2):S40-4. PubMed ID: 1735851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
